The Department of Otolaryngology at Long Island Jewish Medical Center is planning to conduct a 2 year research study for the treatment of RRP. In addition to surgery to remove the papillomas, patients will be given Celebrex (celecoxib) for one year and a placebo for 6 months. Celebrex has been shown to be effective in treating other types of benign tumors. We have applied to NIH for a grant to support the study and will begin to enroll patients in the near future.

To be eligible, patients must be at least 18 years old and must have had at least 3 surgeries in the past year to remove papillomas. If patients are interested, they or their doctors should contact Ginny Mullooly, RN at 718-470-7011 for more information.

We strongly urge patients not to take Celebrex on their own for RRP, since the dose we will be using is not the standard dose and, therefore, should be used as part of a study with appropriate monitoring and evaluation of effects.